[Neurofibromatosis-1 microdeletion syndrome.]

Area of Science:

• Genetics
• Molecular Diagnostics
• Neurocutaneous Disorders

Background:

• Neurofibromatosis type 1 (NF1) is a genetically heterogeneous disorder with varied clinical presentations.
• While intragenic NF1 gene mutations are common, copy number variants (CNVs) are increasingly identified.
• NF1 diagnosis relies on clinical criteria, but molecular diagnostics are crucial for identifying specific genetic causes like microdeletions.

Approach:

• This review summarizes the characteristics and genetic basis of NF1 microdeletion syndrome.
• It analyzes genotype-phenotype correlations to distinguish between point mutations and microdeletions.
• The review categorizes microdeletions into four types based on deletion size and breakpoint location.

Key Points:

• Microdeletions in the NF1 gene region, known as 17q11.2 microdeletion syndrome, account for 5-10% of NF1 cases.
• These microdeletions are associated with a more severe disease phenotype and a higher risk of malignancies.
• Four distinct types of microdeletions are recognized, differing in size and genomic content.

Conclusions:

• Early diagnosis of 17q11.2 microdeletion syndrome is vital for appropriate patient management.
• Close follow-up is essential for individuals diagnosed with NF1 microdeletion syndrome due to potential complications.
• Understanding the molecular genetic landscape of NF1 is key to improving patient outcomes.